 Analgesics
|
|
Anesthetics
|
|
Anti-Addiction/Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products/Modifiers/Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Electrolytes/Minerals/Metals/Vitamins
|
|
 Gastrointestinal Agents
|
Antispasmodics, Gastrointestinal
|
Histamine2 (H2) receptor Antagonists
|
Cimetidine [DG:DG00017]
|
 D00295 Cimetidine (JP17/USP/INN)
D03503 Cimetidine hydrochloride (USP)
|
Famotidine
|
Nizatidine
|
Ranitidine [DG:DG00018]
|
Irritable Bowel Syndrome Agents
|
Laxatives
|
Protectants
|
Proton Pump Inhibitors
|
Gastrointestinal Agents, Other
|
|
Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
|
|
Genitourinary Agents
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
|
Hormonal Agents, Suppressant (Adrenal)
|
|
Hormonal Agents, Suppressant (Pituitary)
|
|
Hormonal Agents, Suppressant (Thyroid)
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
|
Otic Agents
|
|
Respiratory Tract/Pulmonary Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
USP Drug Classification